JPH0212558B2 - - Google Patents
Info
- Publication number
- JPH0212558B2 JPH0212558B2 JP4006481A JP4006481A JPH0212558B2 JP H0212558 B2 JPH0212558 B2 JP H0212558B2 JP 4006481 A JP4006481 A JP 4006481A JP 4006481 A JP4006481 A JP 4006481A JP H0212558 B2 JPH0212558 B2 JP H0212558B2
- Authority
- JP
- Japan
- Prior art keywords
- mutarotase
- glucose
- enzyme
- shows
- activity
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 102000020006 aldose 1-epimerase Human genes 0.000 claims description 36
- 108091022872 aldose 1-epimerase Proteins 0.000 claims description 36
- 241000228212 Aspergillus Species 0.000 claims description 6
- 238000012258 culturing Methods 0.000 claims description 4
- 235000015097 nutrients Nutrition 0.000 claims description 4
- 238000004519 manufacturing process Methods 0.000 claims description 3
- 244000005700 microbiome Species 0.000 claims description 3
- 102000004879 Racemases and epimerases Human genes 0.000 claims 2
- 108090001066 Racemases and epimerases Proteins 0.000 claims 2
- 102000004190 Enzymes Human genes 0.000 description 35
- 108090000790 Enzymes Proteins 0.000 description 35
- 229940088598 enzyme Drugs 0.000 description 35
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 22
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 21
- 230000000694 effects Effects 0.000 description 16
- 239000008103 glucose Substances 0.000 description 16
- 238000000034 method Methods 0.000 description 15
- 239000000243 solution Substances 0.000 description 14
- 230000001580 bacterial effect Effects 0.000 description 10
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 9
- 238000006243 chemical reaction Methods 0.000 description 9
- WQZGKKKJIJFFOK-DVKNGEFBSA-N alpha-D-glucose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-DVKNGEFBSA-N 0.000 description 7
- 235000018102 proteins Nutrition 0.000 description 7
- 102000004169 proteins and genes Human genes 0.000 description 7
- 108090000623 proteins and genes Proteins 0.000 description 7
- 239000000872 buffer Substances 0.000 description 6
- 150000003839 salts Chemical class 0.000 description 6
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 6
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 5
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 5
- 235000011130 ammonium sulphate Nutrition 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 5
- 230000002779 inactivation Effects 0.000 description 5
- 238000005259 measurement Methods 0.000 description 5
- 230000003647 oxidation Effects 0.000 description 5
- 238000007254 oxidation reaction Methods 0.000 description 5
- 239000002244 precipitate Substances 0.000 description 5
- 238000000746 purification Methods 0.000 description 5
- 241000228245 Aspergillus niger Species 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 239000007983 Tris buffer Substances 0.000 description 4
- 239000008351 acetate buffer Substances 0.000 description 4
- 238000010438 heat treatment Methods 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 238000002264 polyacrylamide gel electrophoresis Methods 0.000 description 4
- 239000000758 substrate Substances 0.000 description 4
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 229920002472 Starch Polymers 0.000 description 3
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 3
- 238000005119 centrifugation Methods 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 238000002523 gelfiltration Methods 0.000 description 3
- 235000019698 starch Nutrition 0.000 description 3
- 239000008107 starch Substances 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- WQZGKKKJIJFFOK-SVZMEOIVSA-N (+)-Galactose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-SVZMEOIVSA-N 0.000 description 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 2
- 241000233866 Fungi Species 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 108010071390 Serum Albumin Proteins 0.000 description 2
- 102000007562 Serum Albumin Human genes 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 2
- UDSAIICHUKSCKT-UHFFFAOYSA-N bromophenol blue Chemical compound C1=C(Br)C(O)=C(Br)C=C1C1(C=2C=C(Br)C(O)=C(Br)C=2)C2=CC=CC=C2S(=O)(=O)O1 UDSAIICHUKSCKT-UHFFFAOYSA-N 0.000 description 2
- 229940041514 candida albicans extract Drugs 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 238000000502 dialysis Methods 0.000 description 2
- 238000001962 electrophoresis Methods 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 239000002054 inoculum Substances 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 238000005185 salting out Methods 0.000 description 2
- 238000011218 seed culture Methods 0.000 description 2
- 238000010186 staining Methods 0.000 description 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 239000012138 yeast extract Substances 0.000 description 2
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-DCSYEGIMSA-N Beta-Lactose Chemical compound OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-DCSYEGIMSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 108010053835 Catalase Proteins 0.000 description 1
- 102000016938 Catalase Human genes 0.000 description 1
- 229920000298 Cellophane Polymers 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 102000008857 Ferritin Human genes 0.000 description 1
- 108050000784 Ferritin Proteins 0.000 description 1
- 238000008416 Ferritin Methods 0.000 description 1
- 108010068561 Fructose-Bisphosphate Aldolase Proteins 0.000 description 1
- 102000001390 Fructose-Bisphosphate Aldolase Human genes 0.000 description 1
- 108010015776 Glucose oxidase Proteins 0.000 description 1
- 239000004366 Glucose oxidase Substances 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- 108010058846 Ovalbumin Proteins 0.000 description 1
- 241000228150 Penicillium chrysogenum Species 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 229920005654 Sephadex Polymers 0.000 description 1
- 239000012507 Sephadex™ Substances 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 238000005273 aeration Methods 0.000 description 1
- 102000004139 alpha-Amylases Human genes 0.000 description 1
- 108090000637 alpha-Amylases Proteins 0.000 description 1
- SRBFZHDQGSBBOR-LECHCGJUSA-N alpha-D-xylose Chemical compound O[C@@H]1CO[C@H](O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-LECHCGJUSA-N 0.000 description 1
- 229940024171 alpha-amylase Drugs 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- SRBFZHDQGSBBOR-KLVWXMOXSA-N beta-L-arabinopyranose Chemical compound O[C@H]1CO[C@H](O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-KLVWXMOXSA-N 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 210000000695 crystalline len Anatomy 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 239000000539 dimer Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 229940116332 glucose oxidase Drugs 0.000 description 1
- 235000019420 glucose oxidase Nutrition 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 239000013028 medium composition Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Chemical class 0.000 description 1
- 239000010446 mirabilite Substances 0.000 description 1
- 210000003360 nephrocyte Anatomy 0.000 description 1
- 150000002823 nitrates Chemical class 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 229920001592 potato starch Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- RSIJVJUOQBWMIM-UHFFFAOYSA-L sodium sulfate decahydrate Chemical compound O.O.O.O.O.O.O.O.O.O.[Na+].[Na+].[O-]S([O-])(=O)=O RSIJVJUOQBWMIM-UHFFFAOYSA-L 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 239000008223 sterile water Substances 0.000 description 1
- 235000013547 stew Nutrition 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000001384 succinic acid Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000005846 sugar alcohols Chemical class 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
- 238000002525 ultrasonication Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 229930195724 β-lactose Natural products 0.000 description 1
- 229930028731 β-maltose Natural products 0.000 description 1
Landscapes
- Enzymes And Modification Thereof (AREA)
Description
本発明は、アルドース−1−エピメラーゼを効
率良く製造する方法に関する。
従来、アルドース−1−エピメラーゼ
〔EC5.1.3.3〕(以下ムタロターゼと略する)は、
ベニシリウム・ノタツム(Penicillium
notatum)および種々の動物組織(特に腎蔵、
腸、肝蔵、水晶体など)及び植物組織に存在が知
れ、その作用は、α−D−グルコースとβ−D−
グルコースの変換を触媒する酵素である。
ムタロターゼはグルコー・オキシダーゼ
(EC1.1.3.4:β−Dグルコースのみを基質とす
る)と組み合わせることにより、血清中のグルコ
ースをより迅速に定量することが知られており、
安定性の優たメタロターゼを安価に工業的に製造
する方法を提供することが強く望まれている。
本発明者等はかゝる要望に応えるべく工業的に
安価にムタロターゼを製造する方法について鋭意
研究を重ねた結果、アスペルギルス属に属する微
生物を培養したとき、菌体中に安定性の優れたム
タロターゼが著量に生産されることを見出し、本
発明を完成するに到つた。すなわち本発明はアス
ペルギルス属に属し、ムタロターゼ生産能を有す
る微生物を栄養培地に培養し、該培養物からムタ
ロターゼを採取することを特徴とするムタロター
ゼの製造法である。
本発明において使用可能な菌株は、例えばアス
ペルギルス・ニガー(Aspergillus niger)
ATCC6274(微工研菌寄第10948号)アスペルギル
ス・ニガー(Asp.niger)IAM2020等アスペルギ
ルス属に属し、ムタロターゼを生産する菌はすべ
て本発明方法において使用することができる。
本発明によれば、アスペルギルス属に属する糸
状菌類を栄養培地で培養することにより、ムタロ
ターゼが菌体外又は菌体中に生産蓄積されるの
で、公知の方法及び今後開始されるであろう改良
方法で精製、乾燥することによつて酵素粉末を得
ることが出来る。
更に具体的に説明すると、前記アスペルギルス
属のムタロターゼ生産菌を適当な栄養培地、例え
ば適当な糖質、窒素源、無機塩類を含む培地で培
養し、ムタロターゼを菌体中に蓄積せしめるので
あるが、ここで糖質には、グルコース、シユーク
ロース、マルトース、デン粉加水分解物、デンプ
ンなどの精糖、更にはグリセロール、ソルビトー
ルなどの糖アルコール類、及びクエン酸、コハク
酸などの有機酸などが使用出来る。窒素源として
は、酵母エキス、ペプトン、肉エキス、コーンス
チーブリカー、カゼイン加水分解物、脱脂大豆、
アンモニウム塩、硝酸塩などが使用される。無機
塩類としては、ナトリウム、カリウム、マグネシ
ウム、カルシウムなどの金属塩類や硫酸、リン
酸、塩酸、硝酸などの塩類が使用出来る。
ムタロターゼが菌体外に生産された場合は、菌
体分離後、通常の方法で精製されるが、菌体内に
生産される場合には得られたムタロターゼを含む
菌体を濾過または遠心分離によつて分別し、適当
な緩衝液に懸濁後、磨砕、超音波処理、機械的圧
縮または自行消化などの公知の方法で破砕して酵
素を抽出する。
その抽出液から不溶物を濾過または遠心分離に
よつて分別した後、得られた濾液または上清から
硫酸アンモニウム、芒硝などによる塩析あるいは
アセトン、アルコール等を用いる溶媒沈殿などの
公知の方法で酵素標品を得る。
さらに高度に精製された酵素標品を得るには、
イオン交換を応用した吸着溶出法およびゲル濾過
法及び安定pH範囲内で加熱処理を行い、熱に不
安定な不純蛋白質及び他の酵素を熱失活させる熱
処理を行うとよい。特に、この熱処理は精製の
種々の段階で使用することにより、該酵素の比活
性を大幅に上げる有効な方法である。
ムタロターゼの活性測定は、調製直後のグルコ
ース溶液(グルコース試薬特級、和光製)を使用
する。グルコース溶液(0.2mg/ml)0.5mlにグル
コース測定試薬(ダイヤカラーGC,東洋紡績株
式会社製)2mlと酵素液0.5mlを加え、島津製作
所製ダブルビーム分光光度計UV−210Aで、30
℃、558nmの吸孔度の増加速度よりグルコース酸
化速度を測定する。一方、対照として、上記組成
で酵素無添加で同様な操作を行い、α−D−グル
コースからβ−D−グルコースへの自然の変換速
度を測定し、この量を差引いて1分間に1μモル
のβ−D−グルコースに変換する酵素量を1単位
とする。
第1図にグルコースの酸化に及ぼすムタロター
ゼの効果を示す。第1図中、−△−はムタロター
ゼによるα−グルコース、−〇−はムタロターゼ
による平衡状態のグルコース−●−は平衡状態の
グルコース、−▲−はα−グルコース示す。
第2図にグルコース酸化速度に及ぼすムタロタ
ーゼ濃度の影響を示す。反応速度が2×10-2
(μmole/ml、min)を超える範囲では直線性か
らはずれてくるため、酵素濃度はこの測定範囲に
入るように希釈して測定する。
又、至適pH、基質特異性の測定は旋光度計で
記録して行う。測定方法は基質として1%α−D
−グルコース溶液の変旋光の経時変化を一次反応
と仮定して、ムタロターゼの添加、無添加におけ
る反応速度定数を求め、ムタロターゼ添加の場合
の反応速度定数から無添加の場合の反応速度定数
を差引いて酵素活性とした。
本発明によつて得られるムタロターゼの理化学
的性質をアスペルギルス・ニガー(Aspergillus
niger)ATCC6274(微工研菌寄第10948号)の生
産する酵素について示す。
(1) 作用
本酵素は、α−D−グルコースをβ−D−グ
ルコースに、又はβ−D−グルコースをα−D
−グルコースに変換する反応を触媒する。
(2) 基質特異性
本酵素はα−D−グルコース以外にも、α−
D−ガラクトース、β−D−フルクトース、β
−L−アラビノース及びα−D−キシロース、
β−マルトース、β−ラクトース、β−D−セ
ロビオースに作用する(第1表参照)。
The present invention relates to a method for efficiently producing aldose-1-epimerase. Conventionally, aldose-1-epimerase [EC5.1.3.3] (hereinafter abbreviated as mutarotase) is
Penicillium notatum
notatum) and various animal tissues (especially nephrocytes,
It is known to exist in the intestines, liver, crystalline lens, etc.) and plant tissues, and its action is based on α-D-glucose and β-D-glucose.
An enzyme that catalyzes the conversion of glucose. Mutarotase is known to more rapidly quantify glucose in serum by combining with glucose oxidase (EC1.1.3.4: β-D glucose is the only substrate).
It is strongly desired to provide a method for industrially producing metallotase with excellent stability at low cost. In order to meet such demands, the present inventors have conducted intensive research on a method for industrially producing mutarotase at low cost. As a result, when microorganisms belonging to the genus Aspergillus are cultured, highly stable mutarotase is found in the bacterial cells. It was discovered that this can be produced in significant quantities, and the present invention was completed. That is, the present invention is a method for producing mutarotase, which comprises culturing a microorganism belonging to the genus Aspergillus and capable of producing mutarotase in a nutrient medium, and collecting mutarotase from the culture. Bacterial strains that can be used in the present invention include, for example, Aspergillus niger.
All bacteria that belong to the genus Aspergillus and produce mutarotase can be used in the method of the present invention, such as ATCC6274 (Feikoken Bibori No. 10948) and Aspergillus niger IAM2020. According to the present invention, by culturing filamentous fungi belonging to the genus Aspergillus in a nutrient medium, mutarotase is produced and accumulated outside or inside the fungi, and therefore, known methods and improved methods that will be initiated in the future Enzyme powder can be obtained by purification and drying. More specifically, the mutarotase-producing bacteria of the genus Aspergillus are cultured in a suitable nutrient medium, for example, a medium containing suitable carbohydrates, nitrogen sources, and inorganic salts, and mutarotase is accumulated in the bacterial cells. Examples of carbohydrates that can be used include refined sugars such as glucose, sucrose, maltose, starch hydrolyzate, and starch, as well as sugar alcohols such as glycerol and sorbitol, and organic acids such as citric acid and succinic acid. Nitrogen sources include yeast extract, peptone, meat extract, corn stew liquor, casein hydrolyzate, defatted soybean,
Ammonium salts, nitrates, etc. are used. As the inorganic salts, metal salts such as sodium, potassium, magnesium, and calcium, and salts such as sulfuric acid, phosphoric acid, hydrochloric acid, and nitric acid can be used. When mutarotase is produced outside the bacterial body, it is purified by the usual method after bacterial cell isolation, but when it is produced inside the bacterial body, the resulting bacterial body containing mutarotase is filtered or centrifuged. The enzymes are extracted by separating the enzymes by suspending them in an appropriate buffer, and then crushing them by known methods such as grinding, ultrasonication, mechanical compression, or autogenous digestion. After separating the insoluble matter from the extract by filtration or centrifugation, enzyme preparation is performed from the obtained filtrate or supernatant by a known method such as salting out with ammonium sulfate, Glauber's salt, etc., or solvent precipitation using acetone, alcohol, etc. get goods. To obtain a more highly purified enzyme preparation,
It is preferable to perform an adsorption/elution method applying ion exchange, a gel filtration method, and a heat treatment within a stable pH range to heat-inactivate impure proteins and other enzymes that are unstable to heat. In particular, this heat treatment is an effective method for significantly increasing the specific activity of the enzyme by using it at various stages of purification. To measure the activity of mutarotase, a freshly prepared glucose solution (special grade glucose reagent, manufactured by Wako) is used. Add 2 ml of glucose measurement reagent (Diacolor GC, manufactured by Toyobo Co., Ltd.) and 0.5 ml of enzyme solution to 0.5 ml of glucose solution (0.2 mg/ml), and analyze with a double beam spectrophotometer UV-210A manufactured by Shimadzu Corporation for 30 minutes.
The rate of glucose oxidation is measured from the rate of increase in pore density at 558 nm at 558 nm. On the other hand, as a control, the same operation was performed with the above composition without the addition of enzymes, the natural conversion rate of α-D-glucose to β-D-glucose was measured, and this amount was subtracted to yield 1 μmol per minute. The amount of enzyme converted to β-D-glucose is defined as 1 unit. Figure 1 shows the effect of mutarotase on glucose oxidation. In FIG. 1, -Δ- indicates α-glucose produced by mutarotase, -〇- indicates glucose in an equilibrium state caused by mutarotase, -●- indicates glucose in an equilibrium state, and -▲- indicates α-glucose. Figure 2 shows the influence of mutarotase concentration on the glucose oxidation rate. The reaction rate is 2×10 -2
Since linearity deviates in a range exceeding (μmole/ml, min), the enzyme concentration is diluted and measured so that it falls within this measurement range. In addition, the optimum pH and substrate specificity are measured by recording with a polarimeter. The measurement method is 1% α-D as a substrate.
- Assuming that the change in metarotation light of the glucose solution over time is a first-order reaction, calculate the reaction rate constant with and without the addition of mutarotase, and subtract the reaction rate constant with no addition from the reaction rate constant with the addition of mutarotase. It was defined as enzyme activity. The physicochemical properties of mutarotase obtained by the present invention were investigated in Aspergillus niger.
The following describes the enzyme produced by ATCC6274 (Feikoken Bibori No. 10948). (1) Action This enzyme converts α-D-glucose into β-D-glucose, or converts β-D-glucose into α-D-glucose.
- Catalyze the reaction that converts to glucose. (2) Substrate specificity In addition to α-D-glucose, this enzyme
D-galactose, β-D-fructose, β
-L-arabinose and α-D-xylose,
Acts on β-maltose, β-lactose, and β-D-cellobiose (see Table 1).
【表】
(3) 至適pHおよび安定pH範囲
本酵素の至適pHは前記の活性測定条件下に
おいて、4.0〜8.0の間にある(第3図参照)。
第3図中、−〇−は相対活性、−△−は触媒速度
定数および−▲−は自然速度定数を示す。
本酵素の安定pH域は、20℃、24時間処理で
pH5〜10の範囲にある(第4図参照)。更に最
も安定なpHは5.5〜9付近である。
(4) 作用適温の範囲
本酵素の作用最適温度は前記の活性測定条件
下において、60℃付近にある。
(5) pH、温度などによる失活条件
本酵素はpH6.0、30分間の処理の場合、50℃
まで安定で、60℃、70℃では夫々95%、75%の
活性が残存するが、75℃の処理では殆んど失活
する(第5図参照)。本酵素の75℃における失
活の経時的変化は一分子反応的であり、熱失活
速度定数は0.053mm-1で、即ち6分間で活性の
50%が失活する(第6図参照)。
(6) 分 子 量
SDSポリアクリルアミドゲル電気泳動によ
り、本酵素の分子量は130000と算出された(第
7図参照)。第7図中、〇印は左上から順に
RNA・PT−β′,RNA・P−β′,RNA・P−
β,RNA・PT−β,RNA・PT -I,血清アルブ
ミン、RNA・PT−α,RNA・P−α,
RNA・PT−I,トリブシン・インヒビターを
示す。△印はムタロターゼを示す。
又、セフアデツクスG−200のゲル濾過法に
より分子量を測定すると、260000であつた(第
8図参照)。よつて、この酵素は分子量130000
の2個のサブユニツトからなるダイマーと決定
された。第8図中、〇印は左上から順に、フエ
リチン、カタラーゼ、アルドラーゼ、α−アミ
ラゼ、血清アルブミン、卵アルブミンを示す。
△印はムタロターゼを示す。
次に本発明による新規なムタロターゼの製造法
をアスベルギルス・ニガーATCC6274株(微工研
菌寄第10948号)を用いた実施例で説明する。
実施例
シユークロース3%、馬鈴薯でん粉5%、酵母
エキス(オリエンタル酵母製)0.2%,NaNO32
%,MgSO4・7H2O0.5%を500mlマイヤーフラス
コに仕込み、120℃10分間蒸気滅菌した。種菌と
しては、アスペルギルス・ニガーATCC6274(微
工研菌寄第10948号)のスラント1本に無菌水15
mlを加えブレンダーにかけて胞子懸濁液を調整
し、その5mlを植菌して30℃2日間180nm振巾10
cmの条件で培養して種菌とする。
前述と同様な培地(但しでん粉を抜く)に上記
培養した液5mlを植菌して30℃1日間培養した。
本培養としては、100フアーメンター(丸菱
製、液量70、培地組成は種培養と同一)に種培
養5%を植菌し、30℃で24時間通気(35/分)
撹拌(240rpm)培養しながらpHを5.0〜5.3にな
るように10%NaOHで調製した。
培養終了後、培養液を氷中で冷却しながらガー
ゼで濾過して集菌4.2Kgの湿潤菌体を得た。
この湿潤菌体3.6Kgを0.02Mトリス・0.05M酢酸
緩衝液(pH6.0)と共にホモゲナイザーで破壊
し、さらにダイノミル(シンマルエンタプライズ
製)ですりつぶした8.2の菌体懸濁液を
10000rpmで20分間冷却遠心分離機(トミー精工
製RS−18)で分離して7.78の粗酵素液を得
た。得られた粗酵素液に硫酸アンモニウムを40%
飽和になるように加え一夜放置後、8000rpmで10
分間冷却遠心分離して沈殿を除き、上清液にさら
に硫酸アンモニウムを80%飽和になるように加え
一夜放置後、8000rpmで10分間冷却遠心分離をし
て新規なムタロターゼを沈殿として回収した。
この沈殿に500mlの0.02Mトリス、0.05M酢酸
緩衝液(pH6.0)を加え、数回同一な緩衝液をと
りかえながら一夜透析して生じた沈殿を遠心分離
して除き530mlの酵素液を得た。透析後の酵素液
530mlを緩衝液(pH6.0)で平衡化したDEAE−
セフアデツクスA−50(フアルマシアフアイン
ケミカル社製)を充填したカラム(6.0φ×40cm)
に通して新規なムタロターゼを吸着させ、同緩衝
液で洗浄した後、緩衝液中の食塩濃度を0.05Mか
ら0.5Mに直線的に増加させて、溶出液2.4のう
ち食塩濃度0.35M付近の活性区分(フラクシヨン
No.122〜134)320mlを集めた(第9図参照)。
320mlのうち120mlに硫酸アンモニウムを90%飽
和になるように加え、得られた塩析物を同じ緩衝
液で溶解し、20.8mlに濃縮し、この液5mlをセロ
フアンチユーブで0.02Mトリス・0.05M酢酸緩衝
液(pH6.0)中で一夜透析した。この透析液を70
℃10分間熱処理した後、12000rpmで10分間遠心
分離して沈殿を除き上清液5mlを得た。この液5
mlを、あらかじめ0.02Mトリス・0.05M酢酸緩衝
液(pH6.0)で平衡化したセフアクリルS−300
(フアルマシア製・スエーデン)を充填したカラ
ム(2φ×72cm)に通して活性区分を集めた。
フラクシヨンNo.25は熱処理のため変性した蛋白
質であると考えれる。ここで、フラクシヨンNo.35
の蛋白質のピークとムタロターゼ活性のピークが
一致していることがわかる(第10図参照)。
次いで分子量20000カツトの限外濾過装置(東
洋濾紙製 UHP−76)を用いてフラクシヨンNo.
35の5mlを1mlまで濃縮した。
以上の精製段階の酵素活性を第2表に示す。
蛋白質濃度は、280320nmの吸光度を測定し、
OD80−OD320を算出し、ΔOD=1を酵素液ml当
りの蛋白質0.5mgとして表示した。[Table] (3) Optimal pH and stable pH range The optimal pH of this enzyme is between 4.0 and 8.0 under the above activity measurement conditions (see Figure 3).
In FIG. 3, -0- indicates relative activity, -△- indicates catalytic rate constant, and -▲- indicates natural rate constant. The stable pH range of this enzyme is determined by treatment at 20℃ for 24 hours.
The pH is in the range of 5 to 10 (see Figure 4). Furthermore, the most stable pH is around 5.5-9. (4) Range of optimal temperature for action The optimal temperature for action of this enzyme is around 60°C under the activity measurement conditions described above. (5) Inactivation conditions due to pH, temperature, etc. This enzyme was treated at pH 6.0 and at 50℃ for 30 minutes.
At 60°C and 70°C, 95% and 75% of the activity remains, respectively, but when treated at 75°C, most of the activity is lost (see Figure 5). The time course of inactivation of this enzyme at 75℃ is a single molecule reaction, and the heat inactivation rate constant is 0.053 mm -1 , that is, the activity decreases in 6 minutes.
50% become inactive (see Figure 6). (6) Molecular Weight The molecular weight of this enzyme was calculated to be 130,000 by SDS polyacrylamide gel electrophoresis (see Figure 7). In Figure 7, 〇 marks start from the top left.
RNA・P T −β′, RNA・P−β′, RNA・P−
β, RNA・PT −β, RNA・PT − I, serum albumin, RNA・PT −α, RNA・P−α,
RNA P T -I, tribusin inhibitor. △ indicates mutarotase. The molecular weight was determined to be 260,000 by gel filtration using Cephadex G-200 (see Figure 8). Therefore, this enzyme has a molecular weight of 130,000
It was determined to be a dimer consisting of two subunits. In FIG. 8, the circles indicate ferritin, catalase, aldolase, α-amylase, serum albumin, and egg albumin in order from the top left.
△ indicates mutarotase. Next, the novel method for producing mutarotase according to the present invention will be explained using an example using Asbergillus niger ATCC6274 strain (Feikoken Bibori No. 10948). Example 3% seuclose, 5% potato starch, 0.2% yeast extract (manufactured by Oriental Yeast), NaNO 3 2
%, MgSO 4 .7H 2 O 0.5% was placed in a 500 ml Meyer flask and steam sterilized at 120°C for 10 minutes. As an inoculum, use 1 slant of Aspergillus niger ATCC6274 (Feikoken Bacteria No. 10948) and 15 ml of sterile water.
ml and blended to prepare a spore suspension, inoculate 5 ml and incubate at 180 nm for 2 days at 30°C.
Culture it under cm conditions and use it as an inoculum. 5 ml of the above-mentioned culture was inoculated into the same medium as above (but without starch) and cultured at 30°C for 1 day. For the main culture, 5% of the seed culture was inoculated into a 100 fermenter (manufactured by Marubishi, liquid volume 70, medium composition is the same as the seed culture), and aeration (35/min) was carried out at 30℃ for 24 hours.
The pH was adjusted to 5.0 to 5.3 with 10% NaOH while culturing with stirring (240 rpm). After the cultivation was completed, the culture solution was filtered through gauze while being cooled in ice to obtain 4.2 kg of wet bacterial cells. The 3.6 kg of wet bacterial cells were disrupted with a homogenizer together with 0.02M Tris/0.05M acetate buffer (pH 6.0), and the 8.2 bacterial cell suspension was ground with Dyno Mill (manufactured by Shinmaru Enterprises).
The mixture was separated using a refrigerated centrifuge (Tomy Seiko RS-18) at 10,000 rpm for 20 minutes to obtain a crude enzyme solution of 7.78. Add 40% ammonium sulfate to the obtained crude enzyme solution.
Add to saturation and leave overnight, then 10 at 8000 rpm.
The precipitate was removed by cooling centrifugation for 1 minute, and ammonium sulfate was further added to the supernatant to reach 80% saturation. After standing overnight, the mixture was cooled and centrifuged at 8000 rpm for 10 minutes to recover the novel mutarotase as a precipitate. Add 500ml of 0.02M Tris, 0.05M acetate buffer (pH 6.0) to this precipitate, dialyze overnight while changing the same buffer several times, and remove the resulting precipitate by centrifugation to obtain 530ml of enzyme solution. Ta. Enzyme solution after dialysis
DEAE− equilibrated with 530 ml buffer (pH 6.0)
Cephadex A-50 (Pharmacia Afine)
Column (6.0φ x 40cm) packed with (manufactured by Chemical Co., Ltd.)
After adsorbing the novel mutarotase and washing with the same buffer, the salt concentration in the buffer was increased linearly from 0.05M to 0.5M, and the activity at a salt concentration of around 0.35M in eluate 2.4 was increased. Classification (fraction)
No. 122-134) 320 ml was collected (see Figure 9). Ammonium sulfate was added to 120 ml of the 320 ml to achieve 90% saturation, and the resulting salting out product was dissolved in the same buffer and concentrated to 20.8 ml. 5 ml of this solution was mixed with 0.02M Tris and 0.05M in cellophane tubes. Dialysis was performed overnight in acetate buffer (pH 6.0). 70% of this dialysate
After heat treatment at ℃ for 10 minutes, the mixture was centrifuged at 12,000 rpm for 10 minutes to remove the precipitate and obtain 5 ml of supernatant. This liquid 5
ml of Cephacryl S-300 equilibrated in advance with 0.02M Tris/0.05M acetate buffer (pH 6.0).
The active fraction was collected through a column (2φ x 72cm) packed with (manufactured by Pharmacia, Sweden). Fraction No. 25 is considered to be a protein denatured due to heat treatment. Here, Fraction No. 35
It can be seen that the protein peak and the peak of mutarotase activity coincide (see Figure 10). Next, use an ultrafiltration device with a molecular weight of 20,000 (UHP-76 manufactured by Toyo Roshi) to obtain fraction No.
5 ml of 35 was concentrated to 1 ml. The enzyme activities in the above purification steps are shown in Table 2. Protein concentration was determined by measuring the absorbance at 280 and 320 nm.
OD 80 −OD 320 was calculated, and ΔOD=1 was expressed as 0.5 mg of protein per ml of enzyme solution.
【表】
硫安分画から精製酵素液までの段階で比活性は
4.91U/mg蛋白となり、粗酵素液に比べて約270
倍に増加した。
精製した酵素をデイスクポリアクリルアミドゲ
ル電気泳動及びSDSポリアクリルアミドゲル電気
泳動にかけた。第11図に示すように、蛋白的に
ほぼ単一バンドまで精製されていることがわか
る。第11図中、Aはデイスクポリアクリルアミ
ドゲル電気泳動、BはSDSポリアクリルアミドゲ
ル電気泳動を示す。
なお、デイスクポリアクリルアミドゲル電気泳
動法は、pH9にて濃縮用ゲル2.5%、分離用ゲル
7.5%を使用した。試料の量は200μgを基準とし、
泳動用電流はゲル当り4mA、指示色素としてブ
ロムフエノール・ブルーを使用し、染色はアミド
ブラツクで1時間染色の後、7%酢酸につけて、
時々酢酸をとりかながら脱染色を行つた。
又、SDSポリアクリルアミドゲル電気泳動法
は、7.5%アクリルアミドゲル(pH7.2)を使用し
た。試料(0.1%SDS溶液で希釈)の量はゲル当
り2μgを基準とし、泳動用電流はゲル当り8mA、
指示色素としてブロムフエノール・ブルーを使用
し、染色はコマジーブルーで1時間染色後、7%
酢酸(25%メタノールを含む)に一晩浸漬後、ゲ
ル当り10mAの電流を通じて脱染色を行つた。[Table] Specific activity at the stage from ammonium sulfate fraction to purified enzyme solution
4.91U/mg protein, approximately 270% compared to crude enzyme solution
doubled. The purified enzyme was subjected to disk polyacrylamide gel electrophoresis and SDS polyacrylamide gel electrophoresis. As shown in FIG. 11, it can be seen that the protein was purified to almost a single band. In FIG. 11, A shows disk polyacrylamide gel electrophoresis, and B shows SDS polyacrylamide gel electrophoresis. In addition, disk polyacrylamide gel electrophoresis method uses 2.5% gel for concentration and 2.5% gel for separation at pH 9.
7.5% was used. The amount of sample is based on 200μg,
The electrophoresis current was 4 mA per gel, bromophenol blue was used as the indicator dye, and after staining with amide black for 1 hour, the gel was dipped in 7% acetic acid.
Destaining was performed by occasionally adding acetic acid. In addition, 7.5% acrylamide gel (pH 7.2) was used for SDS polyacrylamide gel electrophoresis. The amount of sample (diluted with 0.1% SDS solution) was based on 2 μg per gel, and the electrophoresis current was 8 mA per gel.
Bromophenol blue was used as the indicator dye, and after staining with Comassie blue for 1 hour, 7%
After overnight immersion in acetic acid (containing 25% methanol), destaining was performed through a current of 10 mA per gel.
第1図はグルコースの酸化に及ぼすムタロター
ゼの効果を示す。第2図はムタロターゼ濃度のグ
ルコース酸化速度に及ぼす影響を示す。第3図は
本発明の方法により得られるムタロターゼの至適
pHを示す。第4図は上記酵素の安定pHを示す。
第5図は上記酵素のpH6.0における温度による失
活条件を示す。第6図は上記酵素の75℃における
熱失活速度を示す。第7図はSDSポリアクリルア
ミドゲル電気泳動による分子量の測定を示す。第
8図はセフアデツクスG−200のゲル濾過法によ
る分子量の測定を示す。第9図はDEAE−セフア
デツクスA−50によるムタロターゼの精製を示
す。第10図はセフアクリル−S−300によるム
タロターゼの精製を示す。第11図はムタロター
ゼのデイスクリポリアクリルアミドゲル電気泳動
及びSDS−ポリアクリルアミドゲル電気泳動Bを
示す。
FIG. 1 shows the effect of mutarotase on glucose oxidation. Figure 2 shows the effect of mutarotase concentration on glucose oxidation rate. Figure 3 shows the optimum mutarotase obtained by the method of the present invention.
Indicates pH. Figure 4 shows the stable pH of the enzyme.
FIG. 5 shows the temperature-dependent inactivation conditions of the enzyme at pH 6.0. Figure 6 shows the rate of heat inactivation of the above enzyme at 75°C. Figure 7 shows the determination of molecular weight by SDS polyacrylamide gel electrophoresis. FIG. 8 shows the measurement of the molecular weight of Cephadex G-200 by the gel filtration method. Figure 9 shows the purification of mutarotase by DEAE-Sephadex A-50. Figure 10 shows the purification of mutarotase by Sephacryl-S-300. FIG. 11 shows discret polyacrylamide gel electrophoresis and SDS-polyacrylamide gel electrophoresis B of mutarotase.
Claims (1)
エピメラーゼ生産能を有する微生物を栄養培地に
培養し、該培養物からアルドース−1−エピメラ
ーゼを採取することを特徴とするアルドース−1
−エピメラーゼの製造法。1 Belongs to the genus Aspergillus, aldose-1-
Aldose-1, which comprises culturing a microorganism capable of producing epimerase in a nutrient medium, and collecting aldose-1-epimerase from the culture.
- Method for producing epimerase.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP4006481A JPS57152885A (en) | 1981-03-18 | 1981-03-18 | Preparation of aldose-1-epimerase |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP4006481A JPS57152885A (en) | 1981-03-18 | 1981-03-18 | Preparation of aldose-1-epimerase |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS57152885A JPS57152885A (en) | 1982-09-21 |
| JPH0212558B2 true JPH0212558B2 (en) | 1990-03-20 |
Family
ID=12570487
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP4006481A Granted JPS57152885A (en) | 1981-03-18 | 1981-03-18 | Preparation of aldose-1-epimerase |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS57152885A (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3531360A1 (en) * | 1985-09-03 | 1987-05-07 | Merck Patent Gmbh | DNA SEQUENCES, RECOMBINANT DNA MOLECULES AND METHOD FOR THE PRODUCTION OF THE ENZYME MUTAROTASE FROM ACINETOBACTER CALCOACETICUS |
| CN110628738B (en) * | 2019-09-27 | 2021-01-12 | 华东理工大学 | Methods, mutants and applications for improving glucose oxidase activity |
-
1981
- 1981-03-18 JP JP4006481A patent/JPS57152885A/en active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPS57152885A (en) | 1982-09-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5387109A (en) | Fructosylamine deglycase and a method of producing it | |
| Every et al. | The purification and properties of extracellular glycosidases of the cellular slime mould Dictyostelium discoideum | |
| US4710470A (en) | Process for producing neuraminidase | |
| KR880001944B1 (en) | 2,5-diketo-d-gluconic acid reductase | |
| JPH11225754A (en) | Aldehyde dehydrogenase | |
| JPS6013668B2 (en) | Method for producing glutathione peroxidase | |
| JPH0117677B2 (en) | ||
| JP3086301B2 (en) | L-Glono-gamma-lactone dehydrogenase | |
| JPH0212558B2 (en) | ||
| Goldman | ENZYME SYSTEMS IN THE MYCOBACTERIA: I. The Isocitric Dehydrogenase | |
| JPH09224660A (en) | Aldehyde dehydrogenase | |
| US5593869A (en) | Method of manufacturing sugars by trehalase | |
| Chiyonobu et al. | Distribution of 2-ketogluconate reductase and 5-ketogluconate reductase in acetic acid bacteria | |
| US4463095A (en) | Process for producing α-glycerophosphate oxidase | |
| JPH0928375A (en) | Trehalose phosphorylase and its preparation method | |
| JPH0518553B2 (en) | ||
| JP3468626B2 (en) | β-glucosidase and method for producing the same | |
| JPS6243666B2 (en) | ||
| JPH07108219B2 (en) | Method for producing NADH oxidase | |
| JPS6341558B2 (en) | ||
| JPS60244286A (en) | Preparation of oxalic acid oxidase | |
| JP3040228B2 (en) | L-fucose dehydrogenase, method for producing the same, and method for quantifying L-fucose | |
| JPS6098982A (en) | Preparation of enzyme for measuring polyamine | |
| JPH01132379A (en) | Novel urease and its production | |
| JPH0133159B2 (en) |